Chao Family Comprehensive Cancer Center
GPTKB entity
Statements (49)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:National_Institutes_of_Health
|
| gptkbp:affiliated_with |
gptkb:University_of_California,_Irvine
|
| gptkbp:clinical_trial |
biomarker studies
phase I trials phase II trials phase III trials quality of life studies survivorship studies combination therapy trials pediatric trials new drug trials prevention studies |
| gptkbp:collaborates_with |
other research institutions
|
| gptkbp:director |
Dr. Richard Van Etten
|
| gptkbp:established_in |
gptkb:1999
|
| gptkbp:focuses_on |
cancer research
|
| gptkbp:has_publications |
gptkb:conference
annual reports newsletters research findings collaborative studies clinical trial results peer-reviewed articles grant proposals patient education materials scientific reviews |
| gptkbp:has_research_areas |
gptkb:Oncology
pediatric oncology translational research cancer prevention hematologic malignancies cancer survivorship gastrointestinal cancer neuro-oncology |
| https://www.w3.org/2000/01/rdf-schema#label |
Chao Family Comprehensive Cancer Center
|
| gptkbp:location |
gptkb:Orange,_California
|
| gptkbp:offers |
clinical trials
|
| gptkbp:part_of |
gptkb:National_Institutes_of_Health
|
| gptkbp:provides |
patient care
|
| gptkbp:receives_funding_from |
gptkb:National_Institutes_of_Health
grants private donations |
| gptkbp:services_provided |
gptkb:immunotherapy
gptkb:surgery radiation therapy chemotherapy targeted therapy |
| gptkbp:bfsParent |
gptkb:UC_Irvine_School_of_Medicine
|
| gptkbp:bfsLayer |
6
|